Zenith Health Care shareholders approved all five resolutions at its 32nd Annual General Meeting held on August 28, 2026. The approvals included the adoption of audited financials for FY26 and key management re-appointments. Notably, promoter votes were invalidated for the material related-party transaction with Achyut Healthcare Limited.

The meeting, conducted via video conferencing from 10:30 am to 10:44 am, saw participation from 39 members, comprising 10 promoters and 29 public shareholders. The statutory auditors’ report and secretarial audit report were submitted without qualifications. As on the record date of August 21, 2026, the company had 38,922 shareholders.

Governance and Management Changes

The board secured shareholder approval for several governance-related resolutions:

• Re-appointment of Mrs. Neela M. Raycha as a director, replacing her term that expired by rotation.
• Re-appointment of Mr. Mahendra C. Raycha as Managing Director for a three-year period from July 1, 2026, to June 30, 2029.
• Regularization of Mr. Akshit M. Raycha’s appointment as Joint Managing Director/Whole Time Director.

These appointments ensure continuity in the company’s leadership structure for the upcoming fiscal year.

Details on Mahendra C. Raycha’s Re-appointment

Mr. Mahendra C. Raycha (DIN: 00577647) was re-appointed as Managing Director by way of special resolution. The early re-appointment was necessitated because he attained the age of 70 years, requiring a fresh special resolution under Section 196 of the Companies Act.

Mr. Raycha is a Chartered Accountant with over 20 years of experience as Managing Director of the company without any break. He holds 6,604,000 equity shares, constituting 12.29% voting power. His monthly remuneration is capped at ₹2,00,000, payable as per the company’s financial convenience. He also holds directorships in Zenith Lifecare Private Limited, Zenith Medicine Private Limited, Ray Remedies Private Limited, and Achyut Healthcare Limited.

Related Party Transaction

Shareholders approved a material related-party transaction with Achyut Healthcare Limited via a special resolution. Pursuant to Section 188 of the Companies Act, 2013, votes cast by promoters, directors, KMPs, and their relatives were treated as invalid. Consequently, 1,52,47,762 votes were declared invalid for this resolution. The resolution passed with 99.95% of valid votes in favor.

Voting Results Overview

The following table summarizes the voting outcomes for the five resolutions placed before shareholders:

All resolutions were passed with the requisite majority. Remote e-voting was conducted through NSDL from August 25 to August 27, 2026. M/s Kamlesh M. Shah served as the scrutinizer for the process.

Zenith Health Care returned to profitability in the first quarter of FY27, reporting a net profit after tax of ₹13.62 lakh for the period ended June 30, 2026. This stands in contrast to the net loss of ₹34.20 lakh recorded in the immediately preceding quarter (Q4FY26) and a marginal loss of ₹1.88 lakh in the corresponding quarter of FY26.

Revenue from operations expanded by 5.6% year-on-year to ₹350.12 lakh, up from ₹331.69 lakh in Q1FY26. The company also saw sequential growth in revenue, rising from ₹271.83 lakh in Q4FY26.

Financial Performance

The Board of Directors approved the unaudited standalone financial results in a meeting held on August 14, 2026. Key financial metrics for the quarter are detailed below:

For the full year ended March 31, 2026, the company reported total income from operations of ₹1,093.65 lakh and a net profit after tax of ₹0.51 lakh.

What the Numbers Show

The return to profitability was supported by improved pre-tax earnings, which stood at ₹18.12 lakh in Q1FY27 compared to a pre-tax loss of ₹42.33 lakh in the previous quarter. The effective tax rate for the quarter was approximately 24.8%, calculated on the net profit before tax figure. There were no exceptional or extraordinary items impacting the results for the current quarter, indicating that the profit turnaround was driven by core operational performance rather than one-off gains.

The company’s paid-up equity share capital remains unchanged at ₹537.39 lakh. Reserves as shown in the audited balance sheet of the previous year stood at ₹205.03 lakh.